← Organon & Co.

Annual Trend FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $7.8b $6.5b $6.3b $6.2b $6.3b $6.4b $6.2b
Cost of Revenue $2.3b $2.1b $2.4b $2.3b $2.5b $2.7b $2.9b
Cost of sales $2.3b $2.1b $2.4b $2.3b $2.5b $2.7b $2.9b
Reconciled Cost Of Revenue $2.3b $2.1b $2.4b $2.3b $2.5b $2.7b $2.9b
Gross Profit $5.5b $4.4b $3.9b $3.9b $3.7b $3.7b $3.3b
Research and development $220.0m $210.0m $443.0m $471.0m $528.0m $469.0m $366.0m
Acquired in-process research and development and milestones — $0 $104.0m $107.0m $8.0m $81.0m $6.0m
Selling, general and administrative $1.4b $1.4b $1.7b $1.7b $1.9b $1.8b $1.7b
Operating expenses:
EBIT $1.5b $1.2b $1.3b $929.0m
Additional Financial Items
Amortization of Intangible Assets — $86.0m $103.0m $116.0m $116.0m $145.0m $205.0m
Foreign Currency Transaction Gain (Loss), before Tax — $5.0m ($18.0m) ($11.0m) ($42.0m) ($26.0m) ($14.0m)
Goodwill, Impairment Loss — — — — — — $301.0m
Income (Loss) from Continuing Operations before Income Taxes, Domestic — $532.0m ($96.0m) ($451.0m) ($554.0m) ($479.0m) ($793.0m)
Income (Loss) from Continuing Operations, Per Basic Share — $9 $5 $4 $4 — —
Income (Loss) from Continuing Operations, Per Diluted Share — $9 $5 $4 $4 $3.33 $0.72
Goodwill impairment — — — — $0 $0 $301.0m
Exchange losses — $44.0m $4.0m $11.0m $42.0m $26.0m $14.0m
Basic (in shares) $253.5m $253.5m $253.5m $254.1m $255.2m $257.0m $259.5m
Diluted (in shares) $253.5m $253.5m $254.2m $255.2m $256.3m $259.2m $260.8m
Diluted EPS — $9 $5 $3.59 $3.99 $3.33 $0.72
Diluted NI Availto Com Stockholders — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Gain On Sale Of Security — $5.0m ($18.0m) ($11.0m) ($42.0m) ($26.0m) ($14.0m)
Impairment Of Capital Assets — — — — $0 $0 $301.0m
Net Income From Continuing And Discontinued Operation — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Net Income From Continuing Operation Net Minority Interest — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Net Interest Income — — — ($422.0m) ($527.0m) ($520.0m) ($504.0m)
Normalized EBITDA — — — $1.9b $1.5b $1.7b $1.7b
Normalized Income — — — $1.0b $1.1b $973.0m $515.6m
Other Special Charges — $0 $104.0m $107.0m $8.0m $81.0m $6.0m
Reconciled Depreciation — — — $212.0m $236.0m $277.0m $361.0m
Restructuring And Mergern Acquisition $78.0m $60.0m $3.0m $28.0m $62.0m $31.0m $95.0m
Selling General And Administration $1.4b $1.4b $1.7b $1.7b $1.9b $1.8b $1.7b
Special Income Charges — — — ($135.0m) ($70.0m) ($112.0m) ($402.0m)
Tax Effect Of Unusual Items — — — ($26.7m) ($23.5m) ($29.0m) ($87.4m)
Tax Provision $390.0m $496.0m $178.0m $205.0m ($350.0m) ($57.0m) $238.0m
Tax Rate For Calcs — — — $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $3.7b $2.8b $1.5b $1.1b $673.0m $807.0m $425.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent — ($96.0m) $0 $0 $0 — —
Total Unusual Items — — — ($146.0m) ($112.0m) ($138.0m) ($416.0m)
Total Unusual Items Excluding Goodwill — — — ($146.0m) ($112.0m) ($138.0m) ($416.0m)
Income before income taxes $3.7b $2.8b $1.5b $1.1b $673.0m $807.0m $425.0m
Pre-Tax Income $3.7b $2.8b $1.5b $1.1b $673.0m $807.0m $425.0m
Net Income Continuous Operations — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Net Income Discontinuous Operations — — $0 $0 $0 — —
Net Income (Loss) Attributable to Parent $3.2b $2.2b $1.4b $917.0m $1.0b $864.0m $187.0m
Net Income Including Noncontrolling Interests — $2.3b $1.4b $917.0m $1.0b $864.0m $187.0m
Earnings Per Share, Basic $12.69 $8.52 $5.33 $3.61 $4.01 $3.36 $0.72
Earnings Per Share, Diluted $12.69 $8.52 $5.31 $3.59 $3.99 $3.33 $0.72
Common Stock, Dividends, Per Share, Declared $12.69 $8.52 $5.33 $1.12 $1.12 $1.12 $0.34
Weighted Average Number of Shares Outstanding, Basic 253.5m 253.5m 253.5m 254.1m 255.2m 257.0m 259.5m
Basic Average Shares $253.5m $253.5m $253.5m $254.1m $255.2m $257.0m $259.5m
Diluted Average Shares $253.5m $253.5m $254.2m $255.2m $256.3m $259.2m $260.8m
Weighted Average Number of Shares Outstanding, Diluted 253.5m 253.5m 254.2m 255.2m 256.3m 259.2m 260.8m
Research and Development Expense — $210.0m $443.0m — — — —
Selling, General and Administrative Expense $1.4b $1.4b $1.7b $1.7b $1.9b $1.8b $1.7b
Restructuring costs $78.0m $60.0m $3.0m $28.0m $62.0m $31.0m $95.0m
Other (income) expense, net $66.0m $35.0m $279.0m $15.0m $15.0m $21.0m ($119.0m)
Interest Expense — $0 $258.0m $422.0m $527.0m $520.0m $504.0m
Current Income Tax Expense (Benefit) — $528.0m $466.0m $223.0m $135.0m $103.0m $175.0m
Interest Expense Non Operating — $0 $258.0m $422.0m $527.0m $520.0m $504.0m
Net Non Operating Interest Income Expense — — — ($422.0m) ($527.0m) ($520.0m) ($504.0m)
Operating Expense — — — $2.2b $2.4b $2.2b $2.1b
Other Income Expense — — — ($161.0m) ($127.0m) ($159.0m) ($297.0m)
Other Non Operating Income Expenses — — — ($15.0m) ($15.0m) ($21.0m) $119.0m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — — — — — ($1.0m) $0
Income Tax Expense (Benefit) $390.0m $496.0m $178.0m $205.0m ($350.0m) ($57.0m) $238.0m
Total Expenses — — — $4.5b $4.9b $4.9b $5.0b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.